Follow
Deborah Kuk
Deborah Kuk
Verified email at mskcc.org - Homepage
Title
Cited by
Cited by
Year
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
AC Huang, MA Postow, RJ Orlowski, R Mick, B Bengsch, S Manne, W Xu, ...
Nature 545 (7652), 60-65, 2017
15122017
Multi-institutional validation study of the American Joint Commission on Cancer changes for T and N staging in patients with pancreatic adenocarcinoma
PJ Allen, D Kuk, C Fernandez-del Castillo, O Basturk, CL Wolfgang, ...
Annals of surgery 265 (1), 185-191, 2017
4792017
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
J Yuan, M Adamow, BA Ginsberg, TS Rasalan, E Ritter, HF Gallardo, Y Xu, ...
Proceedings of the National Academy of Sciences 108 (40), 16723-16728, 2011
4052011
Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma
MCB Tan, MF Brennan, D Kuk, NP Agaram, CR Antonescu, LX Qin, ...
Annals of surgery 263 (3), 593-600, 2016
3122016
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment
SP D’Angelo, AN Shoushtari, NP Agaram, D Kuk, LX Qin, RD Carvajal, ...
Human pathology 46 (3), 357-365, 2015
3092015
The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma
AN Shoushtari, RR Munhoz, D Kuk, PA Ott, DB Johnson, KK Tsai, ...
Cancer 122 (21), 3354-3362, 2016
2822016
An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer
IJ Nixon, LY Wang, JC Migliacci, A Eskander, MJ Campbell, A Aniss, ...
Thyroid 26 (3), 373-380, 2016
2362016
Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis
D Kuk, AN Shoushtari, CA Barker, KS Panageas, RR Munhoz, P Momtaz, ...
The oncologist 21 (7), 848-854, 2016
1902016
Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma: Invasive Mucinous Pattern and Extracellular Mucin Are Associated With: KRAS: Mutation
K Kadota, YC Yeh, SP D’Angelo, AL Moreira, D Kuk, CS Sima, GJ Riely, ...
The American journal of surgical pathology 38 (8), 1118-1127, 2014
1772014
Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid‐type fibromatosis by whole‐exome sequencing and genomic analysis
AM Crago, J Chmielecki, M Rosenberg, R O'Connor, C Byrne, FG Wilder, ...
Genes, Chromosomes and Cancer 54 (10), 606-615, 2015
1672015
Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer
MJ Gollub, DH Gultekin, O Akin, RK Do, JL Fuqua, M Gonen, D Kuk, ...
European radiology 22, 821-831, 2012
1672012
Is port site resection necessary in the surgical management of gallbladder cancer?
AV Maker, JM Butte, J Oxenberg, D Kuk, M Gonen, Y Fong, RP DeMatteo, ...
Annals of surgical oncology 19, 409-417, 2012
1632012
Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity
MR Folkert, S Singer, MF Brennan, D Kuk, LX Qin, WK Kobayashi, ...
Journal of Clinical Oncology 32 (29), 3236-3241, 2014
1612014
Long-term outcomes following microwave ablation for liver malignancies
U Leung, D Kuk, MI D'angelica, TP Kingham, PJ Allen, RP DeMatteo, ...
Journal of British Surgery 102 (1), 85-91, 2015
1482015
Model selection in competing risks regression
D Kuk, R Varadhan
Statistics in medicine 32 (18), 3077-3088, 2013
1452013
Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.
MK Callahan, A Yang, S Tandon, Y Xu, SK Subudhi, RA Roman, AI Heine, ...
Journal of Clinical Oncology 29 (15_suppl), 2505-2505, 2011
1412011
Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes
S Kitano, MA Postow, CGK Ziegler, D Kuk, KS Panageas, C Cortez, ...
Cancer immunology research 2 (8), 812-821, 2014
1402014
Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
J Yuan, J Zhou, Z Dong, S Tandon, D Kuk, KS Panageas, P Wong, X Wu, ...
Cancer immunology research 2 (2), 127-132, 2014
1392014
Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma
ZM Bamboat, LH Tang, E Vinuela, D Kuk, M Gonen, MA Shah, ...
Annals of surgical oncology 21, 1678-1685, 2014
1362014
Defining a valid age cutoff in staging of well-differentiated thyroid cancer
IJ Nixon, D Kuk, V Wreesmann, L Morris, FL Palmer, I Ganly, SG Patel, ...
Annals of surgical oncology 23, 410-415, 2016
1162016
The system can't perform the operation now. Try again later.
Articles 1–20